Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Bull-like who wrote (5645)	9/21/1998 3:20:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

11:06 Defensive, Multinational Stks Up If Rates Drop: Strategist NEW YORK (Dow Jones)--Defensive growth and multinational stocks could thrive into the new year, according to A.G. Edwards & Sons Inc. Chief Equity Strategist Stuart Freeman. Over the next several months, "we think the Fed has a good chance of dropping rates," Freeman told CNBC Monday, suggesting that a rate cut would help these stocks. Defensive growth and multinational stocks were hurt by the dollar's strength in the last few quarters, Freeman said. "A decline in the dollar later in the year would create an attractive environment for these stocks," he said. A decline could add "2% or 3% operating earnings growth for these stocks." Freeman likes Pfizer Inc. (PFE), Procter & Gamble Co. (PG), Coca-Cola Co. (KO) and First Union Corp. (FTU). - Jessica Madore; 201-938-5172 (END) DOW JONES NEWS 09-21-98 11:06 AM

To: Bull-like who wrote (5645)	9/21/1998 3:38:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Da Bull, the strategist apparently agrees with you. Recalling the pessimism over LLY's Evista's sales a couple of months ago and its making new highs recently (doing well today as well), I have high hopes on PFE's price recovery as well. The recent disappointment and lowered expectation on Viagra's sales in North America and future sales in Europe bodes well for Pfizer's future stock price. Viagra will be approved for sale in Canada in November, will probably be approved for sale in Hong Kong by the end of this year (look for exceptional high sales figure here, since the blackmarket V for China would be obtained here). Approval in China would come before the end of 1999. China will be a big market, though probably not as big as Japan, not because of the demographics, but because most of the ED population in China could not afford the drug. Anthony